chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a 60 year old female patient with sulfonamide allergy and no pertinent medical history, who on 15-MAR-2011 was vaccinated with a dose of ZOSTAVAX (Merck) (lot number not reported). Concomitant therapy included SYNTHROID and estrogens cream (unspecified). On 16-MAR-2011 the patient experienced few blisters at the injection site. The patient did not seek medical attention or underwent any diagnositc tests. At the time of the report the patient status was unknown. Follow up information has been received from a registered nurse, concerning herself, a female patient, with no illness at time of vaccination and no adverse events following prior vaccinations, who on 15-MAR-2011, in the morning, was vaccinated SQ into the left arm with the first dose of ZOSTAVAX (Merck) (lot number "1348Z" is an invalid lot number for ZOSTAVAX (Merck)). The nurse indicated that other concomitant therapy also included CYTOMEL and PREVACID. The nurse reported that on 17-MAR-2011 (previously reported as 16-MAR-2011) she woke up with blisters at the site of injection and later in the day, another blister next to it. The nurse also reported that the arm was stinging. The nurse said that 2 vesicles developed and lasted about 4 days. On 21-MAR-2011 the patient recovered. Additional information is not expected.
Pain at site of injection and radiating down arm--became worse as night progressed. Also pain in all joints and weakness of legs.
Tiredness; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness) and MYALGIA (Body ache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced FATIGUE (Tiredness) and MYALGIA (Body ache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FATIGUE (Tiredness) and MYALGIA (Body ache) outcome was unknown. Not Provided          Patient was taking concomitant medication.
sore throat; runny nose; sneezing; This is a spontaneous report from a contactable consumer (patient).  A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 17Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient experienced sore throat, runny nose and sneezing on 18Feb2021. On 19Feb2021, his throat felt better, but he had random throbbing pains in the throat throughout the day and still had runny nose and sneezing. The patient was recovering from the event sore throat while was not recovered from the other events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Within 24 hours post vax, pt developed injection site reaction characterized by redness, swelling and tenderness.  The redness and swelling resolved within 5 days.  A 'very hard small lump' developed and persisted as of 07/21/1999.
Patient received ZOSTAVAX Mon. 11-12-07 - that night full body Rash Appeared, Lightheaded, weak, itching Reported Thursday 11-15-07 - Rash is improving
Fever, Headache, Swelling, Redness, hot around the area of injection.  about 5 inch diameter
7 cm X 7cm warm, redden area to left deltoid.  No treatment.
Patient said that she woke up in the middle of the night because she had severe chest pain and tightness.  Her blood pressure was 196/100 and pulse 81 at 1:20am 2/8/23.  She felt chest pain for the rest of the day and it went away on its own without medical treatment.
1 -Tachycardia for several hours, starting at 1 AM on 07/02/2021. 2 - Ringing in the right ear, high frequency ringing, started on 07/03/2021 and still continues on today (11/02/2021) and getting louder.
Vaccine administered intramuscularly into left deltoid at 1620.  By 1621 patient c/o difficulty breathing and showed s/s of loss of airway.  EMS called while vital signs were being monitored.  All vital signs were WNL save for irregular heart rate and irregular rate of respiration.  EMS on site at 1629 and transported stable patient to ER.
Swelling at injection site Soreness at injection site Very bad headache from 9:30 - 18:30 Fever from 9:30 - 18:30 Roaming joint pain 11:00 - 18:30 Kidney pain 13:00 - 18:30 Teeth ache 15:00 - 16:30 Hot flashes intermittent  Extreme fatigue  I took Tylenol and Aleve at separate times and neither worked until I doubled the recommended dosage of Aleve.   I had to miss work in order to allow my body to recover.
Patient received COVID vaccine at 1550 and immediately started feeling throat tightness/anxiety/sob. Brought over here by clinic staff. A/Ox4/airway patent/sat 100%. Given IM epi.  Given Benadryl, Solu-Medrol, will add on Pepcid continue to monitor on cardiac monitor. Discharge tachycardia noted, secondary to epinephrine. No repeat epinephrine required during ED course. Patient is on daily steroid, we will not add steroid on top of this. Prescribed EpiPen if symptoms were to significantly worsen.
Paralyzed; seizures; Head throbbing; This spontaneous case was reported by a consumer and describes the occurrence of PARALYSIS (Paralyzed) and SEIZURE (seizures) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARALYSIS (Paralyzed) (seriousness criteria disability and medically significant), SEIZURE (seizures) (seriousness criterion medically significant) and HEADACHE (Head throbbing). At the time of the report, PARALYSIS (Paralyzed), SEIZURE (seizures) and HEADACHE (Head throbbing) outcome was unknown.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  No relevant concomitant medications were reported  No treatment information was provided.  Company Comment: Very limited information regarding this events has been provided at this time.  Further information is not expected as the reporter did not allow further contact.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Upon internal review on 22-SEP-2022, non-significant corrections performed to update case received from field.; Sender's Comments: Very limited information regarding this events has been provided at this time.  Further information is not expected as the reporter did not allow further contact.
Patient presents with mother child to address possible vaccine reaction versus cellulitis of the right thigh. He had a flu vaccine 11/2/21 and noted erythema of the area yesterday. This is progressed significantly in the last 12 hours.  He noted yesterday it was itchy though denies pain or itchiness today. No systemic symptoms or fevers. No history of similar reactions or allergies. Tried Benadryl last night with no benefit.
This pharmacist reports that a 60 year old male patient was given a "standard" dose of ZOSTAVAX on 24Oct2012. The patient's relevant medical history, relevant concomitant medications, and relevant past drug history were not reported. In Oct2012, he developed a knot on his arm, and swelling in his arm. It is unknown if there were labs. The events resolved in a couple of days in Oct2012. Additional information has been requested.
5-10 minutes after immunizations, wheeze; bilateral wheeze with poor air entry. Nebulizer treatment with Xoponex 1.25mg. Patient deterioration, perioral cyanosis, pallor, seb q. Epi 0.1mg given 2 times with mild improvement. EMS to ER. Admitted for 1 day. Diagnosis: anaphylaxis. Follow up on 9/16/03 in PMD office; sent to allergist for testing. Per review of hospital records, anaphylaxis is confirmed as the diagnosis.
patient is 15 months old and should not have recieved flumist (given to 2-49 year olds)
Rash after the 2nd dose of Moderna vaccine,rash spreading all over the body, rash still spreading; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash after the 2nd dose of Moderna vaccine,rash spreading all over the body, rash still spreading) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash after the 2nd dose of Moderna vaccine,rash spreading all over the body, rash still spreading). At the time of the report, RASH (Rash after the 2nd dose of Moderna vaccine,rash spreading all over the body, rash still spreading) had not resolved.            No concomitant medications was not provided. Treatment medication was not provided. Action taken with mRNA-1273  in response to the event was not applicable.   Reporter did not allow further contact
Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: Fever-Medium
This female adult patient took the third dose of Vivotif (Batch no.: unknown) at noon, when she developed whelps and hives by evening. The patient is an ER physician and was on duty at that time. She was seen by a colleague and was given Benadryl, Pepcid and 5 day course of Prednisone. When the patient took the 4th capsule the next scheduled day, the same event occurred. She did not have diarroea or fever. The patient fully recovered and will file a VAERS report. Follow-up information was requested on 26. Jan.2009, 26.Feb.2009. Follow-up information was requested on 26.Jan.2009, 26.Feb.2009. Follow-up information received on 26.Feb.2009: Batch no. is not available. The capsules were taken in Jan.2009. The patient is early 30's and has no known allergies. She did not receive concomitant medications. A VAERS report was submitted the same day products received the initial report (19.Jan.2009). No further information can be obtained for this case.
2.5x2.5 inch circle around injection site today, 07/12/21. Inj date 07/09/21. Red, warm with no fever today. Chills and tired on Saturday but no fever ever reported. Pt treated at home with ice and Tylenol. Recommended Benadryl for reaction.
Vaccinations given on 8-10-09, screening questionnaire without "yes" answers. On 8-17-09 phone call received to this office from mom regarding concern about her daughters Hx of GBS & that she was given MCV4 vaccine. No complications or illness in the client to this point.
Swelling of tongue and throat immediately after receiving the shot.  I was able to breath.  Swelling reduced over time until 6pm when it was gone.
Hospitalized 8/4/22-8/6/22 SOB, tachycardia, palpitation, afib, dizziness, PNA, anemia,
Patient was given the pneumonia vaccine, then his regular morning medication. About 5-10 minutes later the patient starting making grunting noises and was unable to follow commands or respond to questions. The episode lasted about 5-10 minutes and the patient returned to normal. Patient stated he "felt funny" after getting the vaccine, but was unable to talk or call for help. He stated he could hear us and see us but could not respond.
Information has been received from a pharmacist concerning a 27 year old female with a penicillin allergy who on 4/10/02 was vaccinated with a dose of MMR II (639570/0698L), 24-48 hrs after vaccination, the pt experienced nausea, vomiting, muscle aches and pains all over her body and a fever of 102 deg F. Subsequently, the pt's symptoms resolved within 72 hrs (on approximately 4/13/02). Unspecified medical attention had been sought. Additional info has been requested.
felt woozy and dizzy; bruising at the injection site; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 47-years-old male patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number and expiration was not reported) via an unspecified route of administration as single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient reported that he received his first vaccine dose and that night he felt woozy and dizzy. Patient also reported that he was on a blood thinner and experienced bruising at the injection site. He reported, it not red, it just looks bruised. The patient asked should he get the second dose after having side effects from the first. It was reported that he should not get the Pfizer-BioNTech COVID-19 Vaccine if he had a severe allergic reaction after a previous dose of the vaccine or if he had a severe allergic reaction to any ingredient of the vaccine. The decision to received the second dose for any other reason could not be made by Pfizer. To refer him to speak to his healthcare provider about the risks of the vaccine compared to the risks of potentially not being fully protected against COVID-19 infection. His healthcare provider knows his health situation and had access to information that can better help inform this decision. The outcome of the events reported as unknown.
High blood pressure. No other lifestyle changes at all. Never had high blood pressure. I was 20-60 above my normal pressure at all times.
was like sleepy; A little bit of fever; This is a spontaneous report from a contactable consumer (patient). A 25-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in left arm on Dec2020 (at the age of 24-years-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history included HIV infection recently diagnosed. The patient's concomitant medications were not reported. The patient reported that it was in December and started having, the symptoms were kind of same. I take the vaccine; I was off for two days after and I was like sleepy and I had just a little bit of fever and stuff like that. But not bad. The patient underwent lab tests and procedures which included blood test: result unknown on an unspecified date and urine analysis: result unknown an unspecified date.  The outcome of the event were recovered on an unspecified date.   Follow-up attempts are completed. No further information is expected. Batch/lot number not available for BNT162B2
Vaccinated at 3:10 pm. Went for a walk at about 5pm for 40 minutes. Resting heart rate that day was 55. O2 was 98%. For the walk my average heart rate was 98. AM BP reading was 87/55. The longer I walked the more I felt a mental fogginess. By the end I could not even remember prayers I have known my entire life. Yes, I was praying or trying to. I honestly wondered if I was having a stroke. I got home and rested and it seemed to go away. I walk every day and  for the next 7 days I had the same effect, but to a lesser degree each day.   I got the first dose on March 18, 2021. Lot number 2613.  Same location. Just felt lethargic and run down for 3-5 days.
Patient was inadvertently given a zoster vaccine instead of a varicella vaccine. Patient reports no untoward effects.
dry cough; irritation rather than a real cough; little bit queasy; fatigued; muscle pain; felt like someone punched me in the arm twice; minor sore arm; felt like someone punched me in the arm; This spontaneous case was reported by an other (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (minor sore arm), FEELING ABNORMAL (felt like someone punched me in the arm), MYALGIA (muscle pain), FEELING ABNORMAL (felt like someone punched me in the arm twice) and NAUSEA (little bit queasy) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 024M20A) for Covid-19 Vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma. Concomitant products included ATORVASTATIN for product use for unkown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (minor sore arm) and FEELING ABNORMAL (felt like someone punched me in the arm). On 24-Feb-2021, the patient experienced MYALGIA (muscle pain) and FEELING ABNORMAL (felt like someone punched me in the arm twice). On 25-Feb-2021, the patient experienced NAUSEA (little bit queasy) and FATIGUE (fatigued). On 26-Feb-2021, the patient experienced COUGH (dry cough) and THROAT IRRITATION (irritation rather than a real cough). On 22-Jan-2021, FEELING ABNORMAL (felt like someone punched me in the arm) had resolved. On 26-Feb-2021, NAUSEA (little bit queasy) and FATIGUE (fatigued) had resolved. On 27-Feb-2021, MYALGIA (muscle pain) and FEELING ABNORMAL (felt like someone punched me in the arm twice) had resolved. At the time of the report, COUGH (dry cough) and THROAT IRRITATION (irritation rather than a real cough) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-034387, MOD-2021-034387 (Patient Link).
he/she can't smell anything, he/she had no taste buds; he/she can't smell anything, he/she had no taste buds; he/she felt nauseating from time to time; he/she felt nauseating after he/she ate like he/she wanted to throw up but he/she didn't he/she meant he/she did throw up twice; really tired; throw up twice; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 via an unspecified route of administration on 17May2021 (Batch/Lot number was not reported) as 2nd dose single dose for covid-19 immunization. Historic vaccine was bnt162b2 via an unspecified route of administration on 17Apr2021 (Batch/Lot number was not reported) as 1st dose single dose for covid-19 immunization. Concomitant medications were not reported. The patient had shot (Unspecified vaccine) on 17th of this month (17May2021) and it had been 2 weeks and on May2021 he/she can't smell anything, he/she had no taste buds, he/she felt nauseating from time to time and he/she was really tired and rested and he/she thought he/she was as far as he/she was going to the bathroom he/she was ok with that, it was that several time he/she felt nauseated at the as he/she can't, he/she can't taste what he/she was eating and the fact that he/she felt like. he/she felt like pretty much during the day he/she felt nauseating after he/she ate like he/she wanted to throw up but he/she don't he/she meant he/she did throw up twice but that was he/she did it twice but he/she did not know if that had anything to do with the vaccine. he/she did have can't smell anything and it had been over 2 weeks and it was really getting weird because he/she got feel healthy but he/she felt tired of that too. He/she was wondering if we heard of anyone with the same deal like sometimes people's body react to it to vaccine little bit different and he/she did have one question he/she was a road truck driver and he/she was supposed to take his/her shot on the 11 (11May2021)which was would have been 21 days after he/she had his/her first one but he/she got it 30 days after he/she got his/her first shot was that still good or did he/she wait too long. The outcome of events was unknown.  Information on Lot/Batch number has been requested.
Dizziness, starting at plus or minus 12:30pm. No other symptoms. (Vaccine adm. at 9:30a.m.). Client had had fasting cholesterol test at 9:20a.m. and reported not having eaten until 2 p.m.
Allergy on face and neck; Face and Neck swollen; Patient took first dose on 5-MAY-2021,Second dose on  June 20, 2021; Rash; This spontaneous case was reported by a patient family member or friend and describes the occurrence of HYPERSENSITIVITY (Allergy on face and neck), SWELLING FACE (Face and Neck swollen), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient took first dose on 5-MAY-2021,Second dose on  June 20, 2021) and RASH (Rash) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 03AB21A and 021Z21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced HYPERSENSITIVITY (Allergy on face and neck), SWELLING FACE (Face and Neck swollen), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient took first dose on 5-MAY-2021,Second dose on  June 20, 2021) and RASH (Rash). At the time of the report, HYPERSENSITIVITY (Allergy on face and neck), SWELLING FACE (Face and Neck swollen) and RASH (Rash) outcome was unknown.            Patient Medical History and Allergies were reported as None.  Treatment information and concomitant medication information was not reported.  The action taken with mRNA-1273 (COVID 19 Vaccine Moderna) (Not applicable) was Not applicable.   This case was linked to MOD-2021-272393 (Patient Link).
minor sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 62-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Apr2023 as dose 6 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 2), administration date: 01Apr2021, when the patient was 60-year-old, for Covid-19 immunization, reaction(s): "Atrial fibrillation", "heart palpitations", "some very slight lesser functioning on the left side of her heart"; Bnt162b2 (DOSE 1), administration date: Mar2021, when the patient was 60 years old, for Covid-19 immunization; Bnt162b2 (DOSE 3), administration date: Sep2021, when the patient was 61 years old, for Covid-19 immunization, reaction(s): "minor sore arm"; Bnt162b2 (DOSE 4), administration date: Apr2022, when the patient was 61 years old, for COVID-19 immunization, reaction(s): "minor sore arm"; Bnt162b2 (DOSE 5), administration date: Sep2022, for Covid-19 immunization, reaction(s): "minor sore arm". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "minor sore arm". Additional information: the dose was given maybe late sometime in Apr2023.   The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300289194 same patient and event, different dose;